UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

BMC infectious diseases, 2010-05, Vol.10 (1), p.116-116, Article 116

2010

Volltextzugriff (PDF)

Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes

Clinical infectious diseases, 2009-01, Vol.48 (2), p.186-193

2009

Volltextzugriff (PDF)

Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity

The Journal of heart and lung transplantation, 2011-11, Vol.30 (11), p.1266-1274

2011

Volltextzugriff (PDF)

New Frontiers of HCV Therapy in HIV/HCV Co-infection

Current HIV/AIDS reports, 2010-08, Vol.7 (3), p.117-126

Amorosa, Valerianna K.

2010

Volltextzugriff (PDF)

Management Complexities of HIV/Hepatitis C Virus Coinfection in the Twenty-First Century

Clinics in liver disease, 2008-08, Vol.12 (3), p.587-609

2008

Volltextzugriff (PDF)

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study

Annals of internal medicine, 2011-09, Vol.155 (6), p.353

2011

Volltextzugriff (PDF)

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin

Journal of the American Academy of Dermatology, 2009-05, Vol.60 (5), p.882-883

2009

Volltextzugriff (PDF)

Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin

AIDS research and human retroviruses, 2016-07, Vol.32 (7), p.660-667

2016

Volltextzugriff (PDF)

Separate Worlds Set to Collide: Smallpox, Vaccinia Virus Vaccination, and Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome

Clinical infectious diseases, 2003-08, Vol.37 (3), p.426-432

2003

Volltextzugriff (PDF)

Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection

BMC musculoskeletal disorders, 2015-04, Vol.16 (1), p.93-93, Article 93

2015

Volltextzugriff (PDF)

Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection

Frontiers in immunology, 2014-07, Vol.5, p.265-265

2014

Volltextzugriff (PDF)

Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients

AIDS and behavior, 2013, Vol.17 (1), p.94-103

2013

Volltextzugriff (PDF)

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients

Antiviral therapy, 2010, Vol.15 (1), p.91-99

2010

Volltextzugriff (PDF)

Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients

Journal of clinical gastroenterology, 2013-05, Vol.47 (5), p.457-460

2013

Volltextzugriff (PDF)

Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy

Journal of the cardiometabolic syndrome, 2008, Vol.3 (2), p.111-114

2008

Volltextzugriff (PDF)

Association between chronic hepatitis C virus infection and low muscle mass in US adults

Journal of viral hepatitis, 2014-12, Vol.21 (12), p.938-943

2014

Volltextzugriff (PDF)

Addition of Nitazoxanide to PEG-IFN and Ribavirin to Improve HCV Treatment Response in HIV-1 and HCV Genotype 1 Coinfected Persons Naïve to HCV Therapy: Results of the ACTG A5269 Trial

HIV clinical trials, 2013-12, Vol.14 (6), p.274-283

2013

Volltextzugriff (PDF)

Strategies to Improve Hepatocellular Carcinoma Surveillance in Veterans With Hepatitis B Infection

Federal practitioner, 2017-06, Vol.34 (Suppl 4), p.S30-S39

2017

Volltextzugriff (PDF)

Incidence and Risk Factors for Incomplete HBV DNA Suppression in HIV/HBV-Coinfected Patients Initiating Tenofovir-Based Therapy

Journal of viral hepatitis, 2013-07, Vol.21 (4), p.288-296

2013

Volltextzugriff (PDF)

Verrucous nodule on the upper lip

Cutis (New York, N.Y.), 2014-02, Vol.93 (2), p.E15-E17

2014

Volltextzugriff (PDF)

Management Complexities of HIV/HCV Coinfection in the Twenty-First Century

Clinics in liver disease, 2008-08, Vol.12 (3), p.587-ix

2008

Volltextzugriff (PDF)

The Influence of Abacavir and Other Antiretroviral Agents on Virologic Response to Hepatitis C Virus Therapy Among Antiretroviral-Treated HIV-Infected Patients

Antiviral therapy, 2010-01, Vol.15 (1), p.91-99

2010

Volltextzugriff (PDF)

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

AIDS (London), 2008-10, Vol.22 (15), p.1919-1927

2008

Volltextzugriff (PDF)

Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177

Journal of acquired immune deficiency syndromes (1999), 2010-08, Vol.54 (4), p.e7-e9

2010

Volltextzugriff (PDF)

Sa1966 A Comparison of the Clinical and Immunological Characteristics in Patients With Acute Hepatitis C With and Without HIV-Coinfection

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-968-S-968

2012

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prevalence and risk factors for significant liver fibrosis among HIV-monoinfected patients

Adherence to Hepatitis C Virus Therapy and Early Virologic Outcomes

Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivity

New Frontiers of HCV Therapy in HIV/HCV Co-infection

Management Complexities of HIV/Hepatitis C Virus Coinfection in the Twenty-First Century

Relationship between adherence to hepatitis C virus therapy and virologic outcomes: a cohort study

Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin

Interferon Stimulated Gene Expression in HIV/HCV Coinfected Patients Treated with Nitazoxanide/Peginterferon-Alfa-2a and Ribavirin

Separate Worlds Set to Collide: Smallpox, Vaccinia Virus Vaccination, and Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome

Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection

Induction of Multiple Immune Regulatory Pathways with Differential Impact in HCV/HIV Coinfection

Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients

The influence of abacavir and other antiretroviral agents on virological response to HCV therapy among antiretroviral-treated HIV-infected patients

Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients

Severe weight gain, lipodystrophy, dyslipidemia, and obstructive sleep apnea in a human immunodeficiency virus-infected patient following highly active antiretroviral therapy

Association between chronic hepatitis C virus infection and low muscle mass in US adults

Addition of Nitazoxanide to PEG-IFN and Ribavirin to Improve HCV Treatment Response in HIV-1 and HCV Genotype 1 Coinfected Persons Naïve to HCV Therapy: Results of the ACTG A5269 Trial

Strategies to Improve Hepatocellular Carcinoma Surveillance in Veterans With Hepatitis B Infection

Incidence and Risk Factors for Incomplete HBV DNA Suppression in HIV/HBV-Coinfected Patients Initiating Tenofovir-Based Therapy

Verrucous nodule on the upper lip

Management Complexities of HIV/HCV Coinfection in the Twenty-First Century

The Influence of Abacavir and Other Antiretroviral Agents on Virologic Response to Hepatitis C Virus Therapy Among Antiretroviral-Treated HIV-Infected Patients

The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis

Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177

Sa1966 A Comparison of the Clinical and Immunological Characteristics in Patients With Acute Hepatitis C With and Without HIV-Coinfection

Suchergebnisse filtern